Francesca Battaglin

Francesca Battaglin

University of Southern California

H-index: 27

North America-United States

About Francesca Battaglin

Francesca Battaglin, With an exceptional h-index of 27 and a recent h-index of 26 (since 2020), a distinguished researcher at University of Southern California, specializes in the field of Medical Oncology, GI Oncology, Pharmacogenomics, Translational Research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Repurposing dihydroergotamine mesylate as a potential MCL-1 inhibitor and its antitumor effect in pancreatic cancer cells

Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.

Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer

Genomic analysis of oesophageal carcinoma (EC) to identify recurrent mutations in histone methyltransferases as a distinctive subset.

A compound targeting the circadian clock protein CRY2 enhances therapeutic efficacy of bevacizumab in a colorectal cancer (CRC) xenograft model

Targeting circadian transcriptional programs in triple negative breast cancer through a cis-regulatory mechanism

Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial.

Francesca Battaglin Information

University

Position

/Norris Comprehensive Cancer Center

Citations(all)

2667

Citations(since 2020)

2364

Cited By

1009

hIndex(all)

27

hIndex(since 2020)

26

i10Index(all)

47

i10Index(since 2020)

43

Email

University Profile Page

University of Southern California

Google Scholar

View Google Scholar Profile

Francesca Battaglin Skills & Research Interests

Medical Oncology

GI Oncology

Pharmacogenomics

Translational Research

Top articles of Francesca Battaglin

Title

Journal

Author(s)

Publication Date

Repurposing dihydroergotamine mesylate as a potential MCL-1 inhibitor and its antitumor effect in pancreatic cancer cells

Cancer Research

Pooja Mittal

Jae Ho Lo

Shivani Soni

Francesca Battaglin

Shradheya RR Gupta

...

2024/3/22

Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.

Karam Ashouri

Yasmine Baca

Joanne Xiu

Shivani Soni

Pooja Mittal

...

2024/1/20

Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).

Karam Ashouri

Yan Yang

Joshua Millstein

Sebastian Stintzing

Aparna Raj Parikh

...

2024/1/20

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer

European Journal of Cancer

Hiroyuki Arai

Yan Yang

Yasmine Baca

Joshua Millstein

Tadamichi Denda

...

2024/2/10

Genomic analysis of oesophageal carcinoma (EC) to identify recurrent mutations in histone methyltransferases as a distinctive subset.

Jingyuan Wang

Joanne Xiu

Matthew James Oberley

Francesca Battaglin

Hiroyuki Arai

...

2024/1/20

A compound targeting the circadian clock protein CRY2 enhances therapeutic efficacy of bevacizumab in a colorectal cancer (CRC) xenograft model

Cancer Research

Jae Ho Lo

Shivani Soni

Goar Smbatyan

Lesly Torres-Gonzalez

Pooja Mittal

...

2024/3/22

Targeting circadian transcriptional programs in triple negative breast cancer through a cis-regulatory mechanism

bioRxiv

Yuanzhong Pan

Tsu-Pei Chiu

Lili Zhou

Priscilla Chan

Tia Tyresett Kuo

...

2024

Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial.

Sandra Algaze

Yan Yang

Joshua Millstein

Shivani Soni

Francesca Battaglin

...

2024/1/20

q-Diffusion leverages the full dimensionality of gene coexpression in single-cell transcriptomics

Communications Biology

Myrl G Marmarelis

Russell Littman

Francesca Battaglin

Donna Niedzwiecki

Alan Venook

...

2024/4/2

Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC).

Francesca Battaglin

Andrew Elliott

Joanne Xiu

Sandra Algaze

Jingyuan Wang

...

2024/1/20

Gender specific role of LMTK3 in neuronal-tumor microenvironment crosstalk in CRC

Cancer Research

Lesly Torres-Gonzalez

Shivani Soni

Yan Yang

Goar Smbatyan

Jae Ho Lo

...

2024/3/22

Genome-wide association study (GWAS) and novel prognostic markers in metastatic colorectal cancer (mCRC).

Yan Yang

Francesca Battaglin

Shivani Soni

Sandra Algaze

Jae Ho Lo

...

2024/1/20

LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).

Lesly Torres-Gonzalez

Francesca Battaglin

Shivani Soni

Yasmine Baca

Joanne Xiu

...

2024/1/20

Structure-based screening for potential ROR1 inhibitors and their potential as antitumor agents in pancreatic cancer cells

Cancer Research

Indrakant Kumar Singh

Shradheya RR Gupta

Pooja Mittal

Shivani Soni

Jae Ho Lo

...

2024/3/22

Analysis of immune-related genes (IRGs) and their potential role in sexual dimorphism in patients (pts) with metastatic colorectal cancer (mCRC).

Pooja Mittal

Yan Yang

Shivani Soni

Francesca Battaglin

Joshua Millstein

...

2024/1/20

CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

Journal for Immunotherapy of Cancer

Francesca Battaglin

Yasmine Baca

Joshua Millstein

Yan Yang

Joanne Xiu

...

2024

Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI …

Alexandra Wong

Nishant Gandhi

Joanne Xiu

Sandra Algaze

Priya Jayachandran

...

2024/1/20

Comparative analysis of the molecular profile and tumor immune microenvironment (TIME) of human epidermal growth factor receptor 2 (HER2) low (L)-versus high (H)-expressing …

Ali Alqahtani

Yasmine Baca

Joanne Xiu

Michael J Hall

Dong Kim

...

2023/2/1

Tissue factor expression in colorectal cancer.

Sandra Algaze

Andrew Elliott

Phillip Walker

Francesca Battaglin

Yan Yang

...

2023/2/1

Targeting the clock pathway to modulate immune response in MSI-high colorectal cancer (CRC): evidence from a preclinical in vivo model

Cancer Research

Shivani Soni

Francesca Battaglin

Sofi Castanon

Jae Ho Lo

Goar Smbatyan

...

2023/4/4

See List of Professors in Francesca Battaglin University(University of Southern California)